Showing items 1–100
1′-cyano nucleoside analogs and uses thereof
Grant US-11939347-B2
United States of America
TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE GLYCOPROTEIN PROCESSING…
Application EP-4106752-A4
European Patent Office
Compounds and methods for treatment of viral infections
Grant US-11926645-B2
United States of America
USE OF MEK1/2 INHIBITORS TO SYNERGISTICALLY POTENTIATE THE ANTIVIRAL EFFECT OF DIRECT-ACTIN…
Application WO-2024042050-A1
World Intellectual Property Organisation (WIPO)
APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF, TIZOXANIDE, IN TREATMENT OF SARS-COV-2…
Application EP-4101449-A4
European Patent Office
Remdesivir treatment methods
Grant US-11903953-B2
United States of America
PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS…
Application EP-3989981-A4
European Patent Office
1′-cyano nucleoside analogs and methods for treatment of viral infections
Grant US-11851438-B2
United States of America
Compounds and methods for treatment of viral infections
Grant US-11845755-B2
United States of America
Compounds and methods for treatment of viral infections
Grant US-11814406-B2
United States of America
Method against severe acute respiratory syndrome coronavirus 2 infection
Grant US-11786530-B2
United States of America
Method for treating coronavirus infections
Grant US-11779585-B2
United States of America
Gel containing pirfenidone
Grant US-11779574-B2
United States of America
Compounds and methods for treatment of viral infections
Grant US-11780844-B2
United States of America
Semi-solid topical composition containing pirfenidone and modified diallyl disulfide…
Grant US-11766426-B2
United States of America
Method for treating coronavirus infections
Grant US-11738025-B2
United States of America
Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient
Grant US-11707444-B2
United States of America
Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
Grant US-11701372-B2
United States of America
Methods for treating SARS CoV-2 infections
Grant US-11660307-B2
United States of America
ALCOHOL-FREE ANTIMICROBIAL HAND SANITIZER
Application WO-2023089433-A2
World Intellectual Property Organisation (WIPO)
Methods for the treatment and prevention of lung infections caused by gram-positive…
Grant US-11633391-B2
United States of America
Methods of treating and inhibiting Ebola virus infection
Grant US-11617753-B2
United States of America
Methods of preparing 1′-cyano nucleosides
Grant US-11613553-B2
United States of America
Methods of reducing virus molecule levels
Grant US-11613750-B2
United States of America
Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2…
Grant US-11597742-B2
United States of America
Topical semisolid composition containing an antimicrobial agent and pirfenidone for the…
Grant US-11576905-B2
United States of America
Antiviral compounds and methods of administration thereof
Application CN-115697328-A
China
THERAPEUTIC AGENT FOR COVID-19
Application WO-2023008530-A1
World Intellectual Property Organisation (WIPO)
유익한 치료방법
Application KR-20230012515-A
Republic of Korea
treatment method
Application KR-20230012514-A
Republic of Korea
Methods and compounds for treating Paramyxoviridae virus infections
Grant US-11492353-B2
United States of America
Remdesivir treatment methods
Grant US-11491169-B2
United States of America
CARBON-BASED ANTIVIRAL NANOPARTICLES
Application WO-2022219521-A1
World Intellectual Property Organisation (WIPO)
NANOPARTICELLE ANTIVIRALI A BASE DI CARBONIO
N/A IT-202100009410-A1
Italy
Use of an N-substituted pyridyl benzisoselazolone compound
Grant US-11464765-B2
United States of America
HUMAN NEUTRALIZING ANTIGEN SPECIFIC PROTEINS FOR SPIKE-RBD OF SARS-COV-2
Application WO-2022200291-A2
World Intellectual Property Organisation (WIPO)
HUMAN NEUTRALIZING ANTIGEN SPECIFIC PROTEINS FOR SPIKE-RBD OF SARS-COV-2
Application EP-4063384-A1
European Patent Office
METHOD AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION
Application US-20220288080-A1
United States of America
Novel triazolyl combretastain derivatives, and composition for prevention or treatment of…
Application KR-20220120299-A
Republic of Korea
TREATMENT
Application WO-2022175689-A1
World Intellectual Property Organisation (WIPO)
Methods for treating Arenaviridae and Coronaviridae virus infections
Grant US-11382926-B2
United States of America
Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing…
Grant US-11369592-B2
United States of America
Epitope identified from SARS-CoV-2 and SARS-CoV-2 multiple-epitope vaccine composition…
Application KR-20220083062-A
Republic of Korea
CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19
Application EP-4008325-A1
European Patent Office
PYRIDYLPYRIDONE DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL…
Application WO-2022115545-A1
World Intellectual Property Organisation (WIPO)
MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION
Application WO-2022115558-A1
World Intellectual Property Organisation (WIPO)
MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION
Application WO-2022115562-A1
World Intellectual Property Organisation (WIPO)
Methods for the preparation of ribosides
Grant US-11344565-B2
United States of America
PYRAZOLO DERIVATIVES AS HUMAN DIHYDROOROTATE DEHYDROGENASE (HDHODH) INHIBITORS FOR USE AS…
Application WO-2022101382-A1
World Intellectual Property Organisation (WIPO)
Niclosamide formulations for treating disease
Grant US-11324708-B1
United States of America
ANTIVIRAL ESSENTIAL OIL COMPOSITIONS
Application WO-2022093141-A1
World Intellectual Property Organisation (WIPO)
Use of Favipiravir in treatment of coronavirus infection
Grant US-11318135-B2
United States of America
ORAL FORMULATION COMPRISING NAFAMOSTAT OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Application WO-2022065789-A1
World Intellectual Property Organisation (WIPO)
PHARMACEUTICAL COMPOSITION COMPRISING CHLOROQUINE AND USES THEREOF
Application WO-2022053693-A1
World Intellectual Property Organisation (WIPO)
PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE AND USES THEREOF
Application WO-2022053694-A1
World Intellectual Property Organisation (WIPO)
METHOD FOR IDENTIFYING AN AGENT MODULATING CELL FUSION OR SYNCYTIA FORMATION AND|COMPOSITIO…
Application WO-2022023380-A3
World Intellectual Property Organisation (WIPO)
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral…
Grant US-11266681-B2
United States of America
Methods for treating Filoviridae virus infections
Grant US-11266666-B2
United States of America
USE OF THIAZOLIDES AGAINST CORONAVIRUSES
Application WO-2022046622-A1
World Intellectual Property Organisation (WIPO)
Methods of treating feline coronavirus infections
Grant US-11260070-B2
United States of America
COMBINATION OF NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND OTHER THERAPEUTIC AGENTS FOR…
Application WO-2022029275-A1
World Intellectual Property Organisation (WIPO)
CRYSTALLINE SALTS OF TIZOXANIDE AND 2-HYDROXY-N-(5-CHLORO-1,3-THIAZOL-2-YL)BENZAMIDE (RM-48…
Application WO-2022020243-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDES, AND COMPOSITION COMPRISING SAME…
Application WO-2022005115-A1
World Intellectual Property Organisation (WIPO)
COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS
Application WO-2021254667-A1
World Intellectual Property Organisation (WIPO)
A PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-VIRAL PROTONOPHORE AND A SERINE PROTEASE…
Application WO-2021255218-A1
World Intellectual Property Organisation (WIPO)
INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ADMINISTRATION OF LACTOFERRIN AND USES…
Application WO-2021222584-A3
World Intellectual Property Organisation (WIPO)
NOVEL METHODS OF USING NITRIC OXIDE DONOR COMPOUNDS FOR TREATMENT OF COVID-19 AND OTHER…
Application WO-2021202317-A3
World Intellectual Property Organisation (WIPO)
SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING TARGETING NANOPARTICLES
Application WO-2021232169-A1
World Intellectual Property Organisation (WIPO)
EZETIMIBE FOR TREATING ENVELOPED VIRUS INFECTIONS
Application WO-2021233956-A1
World Intellectual Property Organisation (WIPO)
A SLEEP-BASED BIOMETRIC TO PREDICT AND TRACK VIRAL INFECTION PHASES
Application WO-2021233769-A1
World Intellectual Property Organisation (WIPO)
COMPOUNDS AND METHODS FOR TREATING ENVELOPED VIRUS INFECTIONS
Application EP-3912624-A1
European Patent Office
METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2
Application WO-2021225767-A1
World Intellectual Property Organisation (WIPO)
METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF HYPOXEMIA
Application WO-2021224146-A1
World Intellectual Property Organisation (WIPO)
ANTIVIRAL USE OF CILENGITIDE
Application WO-2021224234-A1
World Intellectual Property Organisation (WIPO)
METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
Application WO-2021224145-A1
World Intellectual Property Organisation (WIPO)
METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
Application WO-2021224144-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE…
Application WO-2021221043-A1
World Intellectual Property Organisation (WIPO)
METHODS OF TREATING ACUTE LUNG INJURY USING EBSELEN
Application WO-2021217043-A1
World Intellectual Property Organisation (WIPO)
ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING…
Application WO-2021213288-A1
World Intellectual Property Organisation (WIPO)
VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES
Application WO-2021214033-A1
World Intellectual Property Organisation (WIPO)
PHARMACEUTICAL COMPOSITION FOR TREATING SARS-CORONAVIRUS INFECTION, AND MEDICAL USE…
Application WO-2021215798-A1
World Intellectual Property Organisation (WIPO)
VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES
Application EP-3900717-A1
European Patent Office
PIRFENIDONE FOR CORONAVIRUS TREATMENT
Application WO-2021211745-A1
World Intellectual Property Organisation (WIPO)
TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE GLYCOPROTEIN PROCESSING…
Application WO-2021168483-A3
World Intellectual Property Organisation (WIPO)
AEROSOLIZATION OF HCQ OR ITS METABOLITES FOR THE TREATMENT OF LUNG INFECTIONS
Application EP-3892275-A1
European Patent Office
CORONAVIRUS INFECTION TREATMENT DRUG
Application WO-2021200651-A1
World Intellectual Property Organisation (WIPO)
TREATMENT
Application WO-2021198115-A1
World Intellectual Property Organisation (WIPO)
EARLY DRUG INTERVENTIONS TO REDUCE COVID-19 RELATED RESPIRATORY DISTRESS, NEED FOR…
Application WO-2021202546-A1
World Intellectual Property Organisation (WIPO)
FORMULATION
Application WO-2021198116-A1
World Intellectual Property Organisation (WIPO)
CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19
Application WO-2021191305-A1
World Intellectual Property Organisation (WIPO)
ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF
Application WO-2021195661-A1
World Intellectual Property Organisation (WIPO)
HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS
Application WO-2021194890-A1
World Intellectual Property Organisation (WIPO)
ANTIVIRAL COMPOUNDS AND THEIR COMBINATIONS FOR TREATING VIRAL INFECTION WITH SARS-CoV-2
Application FR-3108033-A1
France
METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS INFECTIONS SUCH AS COV-2
Application WO-2021180742-A1
World Intellectual Property Organisation (WIPO)
COMPOSITION COMPRISING DILTIAZEM FOR TREATING A VIRAL INFECTION CAUSED BY SARS-COV-2…
Application WO-2021181044-A1
World Intellectual Property Organisation (WIPO)
VIRAL INFECTION THERAPEUTIC
Application WO-2021182597-A1
World Intellectual Property Organisation (WIPO)
PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUS
Application WO-2021175823-A1
World Intellectual Property Organisation (WIPO)
COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION
Application WO-2021175826-A1
World Intellectual Property Organisation (WIPO)
COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONS
Application WO-2021175857-A1
World Intellectual Property Organisation (WIPO)
Showing items 1–100